Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Human iPSCs Market Size Growth Rate by Type: 2018 VS 2024 VS 2034
1.2.2 Skin
1.2.3 Blood Cells
1.3 Market by Application
1.3.1 Global Human iPSCs Market Growth by Application: 2018 VS 2024 VS 2034
1.3.2 Academic Research
1.3.3 Drug Development and Discovery
1.3.4 Toxicity Screening
1.3.5 Regenerative Medicine
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Human iPSCs Market Perspective (2018-2034)
2.2 Human iPSCs Growth Trends by Region
2.2.1 Global Human iPSCs Market Size by Region: 2018 VS 2024 VS 2034
2.2.2 Human iPSCs Historic Market Size by Region (2018-2023)
2.2.3 Human iPSCs Forecasted Market Size by Region (2024-2034)
2.3 Human iPSCs Market Dynamics
2.3.1 Human iPSCs Industry Trends
2.3.2 Human iPSCs Market Drivers
2.3.3 Human iPSCs Market Challenges
2.3.4 Human iPSCs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Human iPSCs Players by Revenue
3.1.1 Global Top Human iPSCs Players by Revenue (2018-2023)
3.1.2 Global Human iPSCs Revenue Market Share by Players (2018-2023)
3.2 Global Human iPSCs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Human iPSCs Revenue
3.4 Global Human iPSCs Market Concentration Ratio
3.4.1 Global Human iPSCs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Human iPSCs Revenue in 2024
3.5 Human iPSCs Key Players Head office and Area Served
3.6 Key Players Human iPSCs Product Solution and Service
3.7 Date of Enter into Human iPSCs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Human iPSCs Breakdown Data by Type
4.1 Global Human iPSCs Historic Market Size by Type (2018-2023)
4.2 Global Human iPSCs Forecasted Market Size by Type (2024-2034)
5 Human iPSCs Breakdown Data by Application
5.1 Global Human iPSCs Historic Market Size by Application (2018-2023)
5.2 Global Human iPSCs Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Human iPSCs Market Size (2018-2034)
6.2 North America Human iPSCs Market Growth Rate by Country: 2018 VS 2024 VS 2034
6.3 North America Human iPSCs Market Size by Country (2018-2023)
6.4 North America Human iPSCs Market Size by Country (2024-2034)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Human iPSCs Market Size (2018-2034)
7.2 Europe Human iPSCs Market Growth Rate by Country: 2018 VS 2024 VS 2034
7.3 Europe Human iPSCs Market Size by Country (2018-2023)
7.4 Europe Human iPSCs Market Size by Country (2024-2034)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Human iPSCs Market Size (2018-2034)
8.2 Asia-Pacific Human iPSCs Market Growth Rate by Region: 2018 VS 2024 VS 2034
8.3 Asia-Pacific Human iPSCs Market Size by Region (2018-2023)
8.4 Asia-Pacific Human iPSCs Market Size by Region (2024-2034)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Human iPSCs Market Size (2018-2034)
9.2 Latin America Human iPSCs Market Growth Rate by Country: 2018 VS 2024 VS 2034
9.3 Latin America Human iPSCs Market Size by Country (2018-2023)
9.4 Latin America Human iPSCs Market Size by Country (2024-2034)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Human iPSCs Market Size (2018-2034)
10.2 Middle East & Africa Human iPSCs Market Growth Rate by Country: 2018 VS 2024 VS 2034
10.3 Middle East & Africa Human iPSCs Market Size by Country (2018-2023)
10.4 Middle East & Africa Human iPSCs Market Size by Country (2024-2034)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Fujifilm Holding Corporation (CDI)
11.1.1 Fujifilm Holding Corporation (CDI) Company Detail
11.1.2 Fujifilm Holding Corporation (CDI) Business Overview
11.1.3 Fujifilm Holding Corporation (CDI) Human iPSCs Introduction
11.1.4 Fujifilm Holding Corporation (CDI) Revenue in Human iPSCs Business (2018-2023)
11.1.5 Fujifilm Holding Corporation (CDI) Recent Development
11.2 Ncardia
11.2.1 Ncardia Company Detail
11.2.2 Ncardia Business Overview
11.2.3 Ncardia Human iPSCs Introduction
11.2.4 Ncardia Revenue in Human iPSCs Business (2018-2023)
11.2.5 Ncardia Recent Development
11.3 Sumitomo Dainippon Pharma
11.3.1 Sumitomo Dainippon Pharma Company Detail
11.3.2 Sumitomo Dainippon Pharma Business Overview
11.3.3 Sumitomo Dainippon Pharma Human iPSCs Introduction
11.3.4 Sumitomo Dainippon Pharma Revenue in Human iPSCs Business (2018-2023)
11.3.5 Sumitomo Dainippon Pharma Recent Development
11.4 Astellas Pharma Inc
11.4.1 Astellas Pharma Inc Company Detail
11.4.2 Astellas Pharma Inc Business Overview
11.4.3 Astellas Pharma Inc Human iPSCs Introduction
11.4.4 Astellas Pharma Inc Revenue in Human iPSCs Business (2018-2023)
11.4.5 Astellas Pharma Inc Recent Development
11.5 Fate Therapeutics, Inc
11.5.1 Fate Therapeutics, Inc Company Detail
11.5.2 Fate Therapeutics, Inc Business Overview
11.5.3 Fate Therapeutics, Inc Human iPSCs Introduction
11.5.4 Fate Therapeutics, Inc Revenue in Human iPSCs Business (2018-2023)
11.5.5 Fate Therapeutics, Inc Recent Development
11.6 Pluricell Biotech
11.6.1 Pluricell Biotech Company Detail
11.6.2 Pluricell Biotech Business Overview
11.6.3 Pluricell Biotech Human iPSCs Introduction
11.6.4 Pluricell Biotech Revenue in Human iPSCs Business (2018-2023)
11.6.5 Pluricell Biotech Recent Development
11.7 Cell Inspire Biotechnology
11.7.1 Cell Inspire Biotechnology Company Detail
11.7.2 Cell Inspire Biotechnology Business Overview
11.7.3 Cell Inspire Biotechnology Human iPSCs Introduction
11.7.4 Cell Inspire Biotechnology Revenue in Human iPSCs Business (2018-2023)
11.7.5 Cell Inspire Biotechnology Recent Development
11.8 ReproCELL
11.8.1 ReproCELL Company Detail
11.8.2 ReproCELL Business Overview
11.8.3 ReproCELL Human iPSCs Introduction
11.8.4 ReproCELL Revenue in Human iPSCs Business (2018-2023)
11.8.5 ReproCELL Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Human iPSCs Market Size Growth Rate by Type (US$ Million): 2018 VS 2024 VS 2034
Table 2. Key Players of Skin
Table 3. Key Players of Blood Cells
Table 4. Global Human iPSCs Market Size Growth by Application (US$ Million): 2018 VS 2024 VS 2034
Table 5. Global Human iPSCs Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Table 6. Global Human iPSCs Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Human iPSCs Market Share by Region (2018-2023)
Table 8. Global Human iPSCs Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 9. Global Human iPSCs Market Share by Region (2024-2034)
Table 10. Human iPSCs Market Trends
Table 11. Human iPSCs Market Drivers
Table 12. Human iPSCs Market Challenges
Table 13. Human iPSCs Market Restraints
Table 14. Global Human iPSCs Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Human iPSCs Market Share by Players (2018-2023)
Table 16. Global Top Human iPSCs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human iPSCs as of 2024)
Table 17. Ranking of Global Top Human iPSCs Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Human iPSCs Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Human iPSCs Product Solution and Service
Table 21. Date of Enter into Human iPSCs Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Human iPSCs Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Human iPSCs Revenue Market Share by Type (2018-2023)
Table 25. Global Human iPSCs Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 26. Global Human iPSCs Revenue Market Share by Type (2024-2034)
Table 27. Global Human iPSCs Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Human iPSCs Revenue Market Share by Application (2018-2023)
Table 29. Global Human iPSCs Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 30. Global Human iPSCs Revenue Market Share by Application (2024-2034)
Table 31. North America Human iPSCs Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 32. North America Human iPSCs Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Human iPSCs Market Size by Country (2024-2034) & (US$ Million)
Table 34. Europe Human iPSCs Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 35. Europe Human iPSCs Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Human iPSCs Market Size by Country (2024-2034) & (US$ Million)
Table 37. Asia-Pacific Human iPSCs Market Size Growth Rate by Region (US$ Million): 2018 VS 2024 VS 2034
Table 38. Asia-Pacific Human iPSCs Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Human iPSCs Market Size by Region (2024-2034) & (US$ Million)
Table 40. Latin America Human iPSCs Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 41. Latin America Human iPSCs Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Human iPSCs Market Size by Country (2024-2034) & (US$ Million)
Table 43. Middle East & Africa Human iPSCs Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 44. Middle East & Africa Human iPSCs Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Human iPSCs Market Size by Country (2024-2034) & (US$ Million)
Table 46. Fujifilm Holding Corporation (CDI) Company Detail
Table 47. Fujifilm Holding Corporation (CDI) Business Overview
Table 48. Fujifilm Holding Corporation (CDI) Human iPSCs Product
Table 49. Fujifilm Holding Corporation (CDI) Revenue in Human iPSCs Business (2018-2023) & (US$ Million)
Table 50. Fujifilm Holding Corporation (CDI) Recent Development
Table 51. Ncardia Company Detail
Table 52. Ncardia Business Overview
Table 53. Ncardia Human iPSCs Product
Table 54. Ncardia Revenue in Human iPSCs Business (2018-2023) & (US$ Million)
Table 55. Ncardia Recent Development
Table 56. Sumitomo Dainippon Pharma Company Detail
Table 57. Sumitomo Dainippon Pharma Business Overview
Table 58. Sumitomo Dainippon Pharma Human iPSCs Product
Table 59. Sumitomo Dainippon Pharma Revenue in Human iPSCs Business (2018-2023) & (US$ Million)
Table 60. Sumitomo Dainippon Pharma Recent Development
Table 61. Astellas Pharma Inc Company Detail
Table 62. Astellas Pharma Inc Business Overview
Table 63. Astellas Pharma Inc Human iPSCs Product
Table 64. Astellas Pharma Inc Revenue in Human iPSCs Business (2018-2023) & (US$ Million)
Table 65. Astellas Pharma Inc Recent Development
Table 66. Fate Therapeutics, Inc Company Detail
Table 67. Fate Therapeutics, Inc Business Overview
Table 68. Fate Therapeutics, Inc Human iPSCs Product
Table 69. Fate Therapeutics, Inc Revenue in Human iPSCs Business (2018-2023) & (US$ Million)
Table 70. Fate Therapeutics, Inc Recent Development
Table 71. Pluricell Biotech Company Detail
Table 72. Pluricell Biotech Business Overview
Table 73. Pluricell Biotech Human iPSCs Product
Table 74. Pluricell Biotech Revenue in Human iPSCs Business (2018-2023) & (US$ Million)
Table 75. Pluricell Biotech Recent Development
Table 76. Cell Inspire Biotechnology Company Detail
Table 77. Cell Inspire Biotechnology Business Overview
Table 78. Cell Inspire Biotechnology Human iPSCs Product
Table 79. Cell Inspire Biotechnology Revenue in Human iPSCs Business (2018-2023) & (US$ Million)
Table 80. Cell Inspire Biotechnology Recent Development
Table 81. ReproCELL Company Detail
Table 82. ReproCELL Business Overview
Table 83. ReproCELL Human iPSCs Product
Table 84. ReproCELL Revenue in Human iPSCs Business (2018-2023) & (US$ Million)
Table 85. ReproCELL Recent Development
Table 86. Research Programs/Design for This Report
Table 87. Key Data Information from Secondary Sources
Table 88. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Human iPSCs Market Size Comparison by Type (2024-2034) & (US$ Million)
Figure 2. Global Human iPSCs Market Share by Type: 2024 VS 2034
Figure 3. Skin Features
Figure 4. Blood Cells Features
Figure 5. Global Human iPSCs Market Size Comparison by Application (2024-2034) & (US$ Million)
Figure 6. Global Human iPSCs Market Share by Application: 2024 VS 2034
Figure 7. Academic Research Case Studies
Figure 8. Drug Development and Discovery Case Studies
Figure 9. Toxicity Screening Case Studies
Figure 10. Regenerative Medicine Case Studies
Figure 11. Others Case Studies
Figure 12. Human iPSCs Report Years Considered
Figure 13. Global Human iPSCs Market Size (US$ Million), Year-over-Year: 2018-2034
Figure 14. Global Human iPSCs Market Size, (US$ Million), 2018 VS 2024 VS 2034
Figure 15. Global Human iPSCs Market Share by Region: 2024 VS 2034
Figure 16. Global Human iPSCs Market Share by Players in 2024
Figure 17. Global Top Human iPSCs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human iPSCs as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Human iPSCs Revenue in 2024
Figure 19. North America Human iPSCs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 20. North America Human iPSCs Market Share by Country (2018-2034)
Figure 21. United States Human iPSCs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 22. Canada Human iPSCs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 23. Europe Human iPSCs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 24. Europe Human iPSCs Market Share by Country (2018-2034)
Figure 25. Germany Human iPSCs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 26. France Human iPSCs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 27. U.K. Human iPSCs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 28. Italy Human iPSCs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 29. Russia Human iPSCs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 30. Nordic Countries Human iPSCs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 31. Asia-Pacific Human iPSCs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 32. Asia-Pacific Human iPSCs Market Share by Region (2018-2034)
Figure 33. China Human iPSCs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 34. Japan Human iPSCs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 35. South Korea Human iPSCs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 36. Southeast Asia Human iPSCs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 37. India Human iPSCs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 38. Australia Human iPSCs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 39. Latin America Human iPSCs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 40. Latin America Human iPSCs Market Share by Country (2018-2034)
Figure 41. Mexico Human iPSCs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 42. Brazil Human iPSCs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 43. Middle East & Africa Human iPSCs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 44. Middle East & Africa Human iPSCs Market Share by Country (2018-2034)
Figure 45. Turkey Human iPSCs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 46. Saudi Arabia Human iPSCs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 47. Fujifilm Holding Corporation (CDI) Revenue Growth Rate in Human iPSCs Business (2018-2023)
Figure 48. Ncardia Revenue Growth Rate in Human iPSCs Business (2018-2023)
Figure 49. Sumitomo Dainippon Pharma Revenue Growth Rate in Human iPSCs Business (2018-2023)
Figure 50. Astellas Pharma Inc Revenue Growth Rate in Human iPSCs Business (2018-2023)
Figure 51. Fate Therapeutics, Inc Revenue Growth Rate in Human iPSCs Business (2018-2023)
Figure 52. Pluricell Biotech Revenue Growth Rate in Human iPSCs Business (2018-2023)
Figure 53. Cell Inspire Biotechnology Revenue Growth Rate in Human iPSCs Business (2018-2023)
Figure 54. ReproCELL Revenue Growth Rate in Human iPSCs Business (2018-2023)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed